- Staat
- IA
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 06.10.2022
- Beginn
- 06.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cataplexy
Eye movement disorder
Fall
Head injury
Headache
Syncope
Unresponsive to stimuli
Symptomtext
PATIENT RECEIVED 3 VACINATIONS, HEPB, IPOL, AND VARIVAX IN THAT ORDER. WHEN SHE RECEIVED THE VARIVAX SHE WENT LIMP, EYES ROLLED BACK, FAINTED, FELL OF HER CHAIR, AND HIT HER HEAD. IT TOOK A MINUTE FOR HER EYES TO OPEN AND 4 TO 5 MINUTES TO BECOME RESPONSIVE. MOTHER REFUSED EMS INTERVENTION OR TO GO TO AN URGENT CARE. CALLED PATIENT THE NEXT DAY SHE IS FEELING OK BUT HAS HEADACHE AND BUMP ON HER HEAD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,1
- Geschlecht
- M
- Eingang
- 26.04.2022
- Impfdatum
- 22.04.2022
- Beginn
- 22.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Febrile convulsion
Injection site rash
Pyrexia
Symptomtext
Certified medical assistant was getting vaccines ready and she accidentally drew up a ProQuad instead of an MMR. Patient tolerated vaccines well, and parent was informed of what to watch for: Fevers/ febrile seizures/ and rash around the injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Febrile convulsion
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Left OM/ URI on 4/11/2022 (finished abx)
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 29.06.2023
- Impfdatum
- 07.12.2022
- Beginn
- 07.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Injection site erythema
Injection site swelling
Irritability
Symptomtext
Patient received combination MMRV instead of MMR and was also given stand-alone varicella, resulting in double dose of varicella being administered. Mom states patient seemed to be more irritable than usual after vaccine administration, and the injection site was redder and more swollen than with other vaccines previously administered. Mom did not feel the need to initiate follow up care based on patient reaction and side effects resolved on their own.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- ear infection, croup, dermatitis
- Vorgeschichte
- constipation
- Andere Medikamente
- Miralax
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 22.07.2022
- Impfdatum
- 22.04.2022
- Beginn
- 23.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Pyrexia
SARS-CoV-2 test negative
Symptomtext
Developed fever up to 101 on same day as vaccine administration. Maintained Fever For 5 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- COVID TEST - NEGATIVE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 1,2
- Geschlecht
- F
- Eingang
- 08.06.2022
- Impfdatum
- 03.06.2022
- Beginn
- 04.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- SC / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Decreased appetite
Malaise
Pyrexia
Vomiting
Symptomtext
patient with 4+ days ongoing fever, vomiting, anorexia, malaise
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- -
- Beginn
- 19.05.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site infection
Pyrexia
Rash
Symptomtext
45 yo female received varicella vax. Developed 14"x14" Rash, high fever and infection to injection area.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site infection
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- No conditions
- Andere Medikamente
- Prednisone - 100 mg Amoxicillin
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- 21.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Injection site pruritus
Injection site rash
Injection site warmth
Symptomtext
Subcutaneous vaccine injection site developed in to large, hot, itching rash about the size of an adult hand. Patient took pictures and went to local emergency room for reaction on 04/21/2022. Emergency room physician prescribed unknown steroid cream for patient to apply. Rash resolved within 7 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 10.05.2022
- Impfdatum
- 21.04.2022
- Beginn
- 07.05.2022
- Tage bis Beginn
- 16,0
- Dosis
- 1
- Route/Site
- - / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Symptomtext
Onset 5/7/22 of widespread rash. Started with spots on thighs and then spread all over body. No treatment needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- diagnosed with Covid-19 on 4/26/22
- Vorgeschichte
- None
- Andere Medikamente
- Augmentin started on 4/26/22 for otitis Cefdinir started on 5/2/22 for pneumonia
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 05.04.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Flushing
Injection site swelling
Injection site urticaria
Irritability
Symptomtext
Immediately after injection hive developed at the site of injection. Fussy. Normal vitals. No resp distress. No swelling other than at injection site. Mildly flushed but no other hives developed. Given Benadryl with mild improvement in hive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- mild nasal congestion that mom attributed to teething
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 18.03.2022
- Impfdatum
- 07.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 9,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pyrexia
Rash
Symptomtext
3/16/22 night started with small rash and mild fever on 3/17/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Erythema
Injection site induration
Injection site swelling
Pain
Pruritus
Symptomtext
itching after injection, some redness. The following morning the patient noticed swelling and induration around the injection site. the swelling. there was continued significant swelling, redness, itching, hardness, and pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site induration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 04.09.2023
- Impfdatum
- 14.08.2023
- Beginn
- 14.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; patient received an expired dose of MMR II and an expired dose of VARIVAX. The patient received both vaccines on 8/14/2023. The MMR II expired 8/4/2023 and the VARIVAX expired 8/10/2023. Caller stated the pro; This spontaneous report was received from a medical assistant and refers to a 50-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-AUG-2023, the patient was vaccinated with a first dose measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, which had a lot #U024229, with expiration date: 04-AUG-2023 (Expired drug administered), administered for prophylaxis (strength was not provided); and also vaccinated with a first dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #U024765, expiration date: 10-AUG-2023 (Expired drug administered), administered for prophylaxis (strength was not provided) both vaccines were given subcutaneously. No treatment was required for the experience. The reporter stated the vaccines had no temperature and the patient had not reported any symptoms or adverse event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.09.2022
- Impfdatum
- 25.08.2022
- Beginn
- 25.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
no adverse event; one dose of VARIVAX and one dose of MMR II that experienced a temperature excursion was administered to a single patient; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, drug reactions or allergies, pertinent medical history and concomitant therapy were not reported. On 25-AUG-2022, the patient was vaccinated with improperly store doses of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U024765, expiration date 10-AUG-2023 and a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), lot # T034388, expiration date 08-OCT-2023 (dose and route were not reported) for prophylaxis (product storage error). Concomitant therapies included sterile diluent. The vaccines were exposed to 10.1 Celsius for 1 hour and 30 minutes and to -11.5 Celsius for 4 hours and 30 minutes. There was no previous temperature excursion. There was no additional adverse event and nor product quality complain reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; HCP called in to report a temperature excursion on VARIVAX and PROQUAD. HCP reports that 9 patients were administered VARIVAX. HCP reports that the VARIVAX administrations occurred on 6/21/22, 6/23/22, 6/27/22, and 6/28/22. The patients involved in t; This spontaneous report was received from the medical assistant and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unspecified date in June 2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024765, expiration date: 10-AUG-2023, for prophylaxis (dose, strength, route of administration and anatomical location were not provided). The vaccine was administered after the temperature excursion (product storage error). No additional adverse event reported. This is one of the 14 reports from the same reporter.; Sender's Comments: US-009507513-2206USA008492:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 19.04.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Syringe issue
Symptomtext
Unknown amount of the Pedvax Hib administered/injected due to spill of vaccine from syringe.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Anemia, atopic dermatitis, bronchiolitis, right inguinal hernia, seborrheic dermatitis
- Vorgeschichte
- -
- Andere Medikamente
- White petroleum Jelly Topical, Tri-vi-sol, hydrocortisone, Benadryl, Ary Saline nasal drops, albuterol sulfate, ferrous sulfate, hydrocortisone 1%, acetaminophen
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental overdose
No adverse event
Product confusion
Wrong product administered
Symptomtext
No additional adverse event reported, no further information provided; The patient was vaccinated with PROQUAD instead of M-M-R II; The patient was vaccinated with PROQUAD instead of M-M-R II which was concomitantly given with a dose of VARIVAX; Product confusion; This spontaneous report was received from a registered nurse referring to a 1-year-old patient of unknown gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were not reported. On 15-FEB-2022, the nurse had product confusion on measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, once (Lot# U028179 and expiration date : 08-MAR-2023) as prophylaxis instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (vaccine not administered) (Lot# and expiration date, exact dose and frequency were not reported) as prophylaxis which was concomitantly given with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, once (Lot# U024765 and expiration date : 10-AUG-2023) as prophylaxis (product confusion) (wrong product administered) (accidental overdose). No additional adverse event reported, no further information provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 24.02.2022
- Impfdatum
- 23.02.2022
- Beginn
- 24.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Computerised tomogram head
Electrocardiogram
Full blood count
Hypotonia
Unresponsive to stimuli
Urine analysis
Symptomtext
Patient was found unresponsive at 6:00am this morning when mom went to wake her for the day. She was limp, breathing normally, and taken immediately to the local Emergency Room when she finally came around after a little while. Further work up/evaluation is currently being done
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Computerised tomogram head
- Hospital-Tage
- -
- Labordaten
- CBC, Urinalysis, Head CT, EKG 2/24/2022 Other tests possibly pending depending on results and patient
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 24.02.2022
- Impfdatum
- 24.02.2022
- Beginn
- 24.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Product administered to patient of inappropriate age
Product administration error
Wrong product administered
Symptomtext
Patient seen in office for routine 1 year check up. During immunizations a combination MMR/Varicella vaccine given instead of single MMR. Patient was also given single Varicella in separate extremity. Error identified upon entry into administration record. Provider notified who will reach out to the family to discuss.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Ear Infection
- Vorgeschichte
- -
- Andere Medikamente
- Cefdinir
- Allergien
- Amoxicillin
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 21.02.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No additional adverse events reported; A dose of PROQUAD was administered instead of MMR II, that was concomitantly given with a dose of VARIVAX to a 1 year old child by mistake today; A dose of PROQUAD was administered instead of MMR II, that was concomitantly given with a dose of VARIVAX to a 1 year old child by mistake today; This spontaneous report was received from a registered nurse referring to a 1-year-old patient. The patient's current condition, pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 15-FEB-2022, nurse stated a dose of vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # U029179 and expiration date upon internal validation was 08-MAR-2023), 0.5ml was administered instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant human albumin (rHA) (M-M-R II), that was concomitantly given with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # U024765 and expiration date upon internal validation was 10-AUG-2023), , 0.5 ml to a 1 year old child by mistake on same day for prophylaxis (wrong product administered and Accidental overdose). No other information given. No additional adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -